2021 American Transplant Congress

TOPIC: Clinical Science » Liver

Early Reduction of Tacrolimus Trough Levels Improves Long-term Kidney Function without Increase in Incidence of Acr
M. Chen¹, B. Loza¹, A. Chang¹, R. Byfield², K. Olthoff¹, A. Shaked¹
Effect of Early Biopsy-Proven Rejection on Liver Transplant Outcomes
D. D. Aufhauser, N. Marka, L. Stalter, G. Levenson, D. Al-Adra, D. P. Foley
Effects of Timing of Everolimus Transition on Renal Outcomes in Liver Transplant Recipients
M. Leick¹, H. Belleau², T. McCashland³
Effects of TIPS on Transplant Outcomes for HCC
C. L. Hanlon¹, D. Toy¹, Y. Liu¹, S. Zhou¹, K. Zhou², J. Kahn², L. Yuan²
Elevated BMI (>28) and High Titer ANA are the Most Common Causes of Abnormal Selective Pre-donation Liver Biopsies in Living Liver Donors
J. Cisek
Evaluation of Increasing Liver Discard Rate and Waiting List Drop-Off in Post-MELD Era
R. Matsumoto¹, K. Halazun², J. Emond¹, B. Samstein², R. S. Brown Jr.², L. Dove¹, T. Kato¹
Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
H. Bakhtiari¹, S. Todd², H. Snyder², D. Lo², M. Flynn²
Excellent Pathological Response with Gemcitabine-based Protocol in Patient with Hilar Cholangiocarcinoma
A. Saharia¹, R. McMillan¹, S. Kodali¹, M. Javley², C. M. Mobley¹, M. J. Hobeika¹, A. Shetty¹, D. W. Victor¹, R. McFadden¹, M. Abdelrahim¹, K. Heyne¹, A. O. Gaber¹, R. M. Ghobrial¹
Extreme Hyponatremia as a Risk Factor for Early Mortality After Liver Transplantation in the MELD-Sodium Era
T. Ivanics¹, S. Leonard-Murali¹, H. Mouzaihem¹, D. Moonka², T. Kitajima¹, S. Yeddula¹, T. Shamaa¹, M. Rizzari¹, K. Collins¹, A. Yoshida¹, M. Abouljoud¹, S. Nagai¹
Geographic Divergence in Waitlist Registration and Trends in Waitlist Removal for Liver Transplantation in Patients with Nonalcoholic Steatohepatitis (NASH)
C. Hanlon¹, B. Saberi², L. Yuan¹

« Previous Page
1
…
4
5
6
7
8
…
19
Next Page »